AI in Healthcare: Bridging Technology and Humanity
Artificial Intelligence (AI) is increasingly present in our society and also has more and more applications in the medical world. Throughout these two dynamic and engaging days, we will highlight different viewpoints on AI in Healthcare together with the challenges and possible risks of AI applications in healthcare. As a decision-maker, medical or technology expert, you will be given the necessary tools to engage in dialogue and address common challenges in developing and implementing AI in the sector.
Each half-day session will feature three insightful talks, followed by a moderated debate. During these debates, we will integrate and discuss the three key aspects covered in the talks, providing a comprehensive understanding of AI's impact on healthcare.
Practical information:
Want to register?
- Register until: 26 May 2025
- Price: €300 - 500
An application for RIZIV accreditation has been submitted for this training.
Leertraject
Each half-day session will feature three insightful talks, followed by a moderated debate. During these debates, we will integrate and discuss the three key aspects covered in the talks, providing a comprehensive understanding of AI's impact on healthcare.
Programme
Setting the Scene: AI in Healthcare
4 June 2025
Advancing Healthcare: Technology and AI Innovations
- AI in the current medical technology landscape
Prof. Tom Braekeleirs, Ghent University - GenAI in Healthcare
Prof. dr. Kirsten Colpaert, MD, Data Science Institute & UZ Ghent - AI-enabled health monitoring outside the hospital
Prof. dr. Maarten De Vos, KU Leuven ESAT STADIUS & UZ Leuven
Human Interaction in Healthcare: The Role of AI
- Why we should (not) worry about generative AI: personal experience and philosophical reflections on responsibilities, intelligence, and bullshit
Prof. dr. Seppe Segers, Ghent University - Data sharing and privacy: an oxymoron in the age of digital technology and artificial intelligence
Prof. dr. ir. Yves Moreau, KU Leuven ESAT STADIUS - Navigating between assistance and automation: Perspectives on AI’s reshaping of relationships between healthcare providers
Prof. dr. Sigrid Sterckx, Ghent University
Human Interaction in Healthcare
18 June 2025
Foundations of AI: Data, Evaluation, and Validation
- Enabling trustworthy decision making in healthcare
Prof. dr. ir. Sofie Van Hoecke, IDLab, UGent-imec - Data-Driven Healthcare
Prof. dr. Peter De Jaeger, AZ Delta - AI for Causal Learning: A Smooth Path to Evidence or Evidence on Thin Ice?
Prof. dr. Stijn Vansteelandt, Ghent University
Integrating AI: Data, Devices, and Legal Considerations
Discussions, moderated by Sofie Bekaert, King Baudouin Foundation & Ghent University
- AI Act in Medicine
AI Act in Medicine - Anastasyia Kiseleva, VUB
vs. Medical Device Regulation (MDR) / AI Act - Lieselot Burggraeve, Ghent University & Azalea Vision - European Health Data Space (EHDS)
European Health Data Space (EHDS) - Prof. dr. Griet Verhenneman, Ghent University
vs. Data Quality - Jens Declerk, i~HD, European Institute for Innovation Through Health Data - AI Liability
Liability Dr. Sofia Palmieri, i~HD, European Institute for Innovation Through Health Data
vs. AI Liability Sylvie Tack, Sanalex, Ghent University, UAntwerpen
Abstracts
AI in the current medical technology landscape
By prof. Tom Braekeleirs, Ghent University
AI is front and center, also in Healthcare. But it is not a standalone evolution. When understanding how it all fits together, we can better understand how to navigate the complicated landscape of technology in healthcare and how to make AI acceptable.
GenAI in Healthcare
By prof. dr. Kirsten Colpaert, MD, Data Science Institute & UZ Ghent
Generative AI (GenAI) is making its way into healthcare, offering new ways to generate text, synthesize data, and support clinical reasoning. Its potential spans from drafting patient letters to assisting in diagnostic processes and training models from unstructured data. But alongside the promise come important challenges: how do we ensure these tools are accurate, safe, and aligned with clinical workflows? In this talk, we will explore current and emerging use cases of GenAI in healthcare, including clinical decision support, while also discussing limitations, feasibility, and the risk of cognitive bias when humans and AI systems interact. We’ll reflect on where GenAI can make a real impact today — and where caution is still warranted.
AI-enabled health monitoring outside the hospital
By prof. dr. Maarten De Vos, KU Leuven ESAT STADIUS & UZ Leuven
Wearables allow to monitor patients outside of a traditional hospital context. However, there is no human expert capacity to review such tsunami of data. The only solution is to have robust and reliable AI solutions that (pre-) analyse the data. In this talk, we will review some of the solutions to bridge the gap between technical developments in wearable brain monitoring and clinical utility outside of the hospital. We will focus on applications of sleep and epilepsy, and question generalisability, explainability and uncertainty of the approaches.
Why we should (not) worry about generative AI: personal experience and philosophical reflections on responsibilities, intelligence, and bullshit
By prof. dr. Seppe Segers, Ghent University
AI is often seen as a disruptive innovation, but what exactly does it disrupt? This talk explores possible effects of AI on understandings of human agency, responsibility, and expertise, particularly in healthcare and academia. In medicine, AI-driven decisions raise ethical concerns: Who is responsible when an AI-based diagnosis leads to harm? Does AI challenge traditional moral frameworks, or merely highlight existing gaps? Similarly, in education, large language models may blur the lines between human and machine-generated knowledge, prompting us to rethink originality, authorship, and assessment. Beyond practical concerns, AI triggers philosophical questions about whether AI is truly intelligent (and what that might mean)? From this I hope to arrive at more philosophical musings about how artificial and how intelligent ‘artificial intelligence’ is, and how such technology relates to human and academic praxis as it relates to ‘truth’. The latter element will briefly engage with Harry Frankfurt’s work ‘On Bullshit’.
Data sharing and privacy: An oxymoron in the age of digital technology and artificial intelligence
By prof. dr. ir. Yves Moreau, KU Leuven ESAT STADIUS
The rapid accumulation of genomic and medical data and the need to share this data among researchers and clinicians for research and better clinical care creates important tensions between data openness and privacy. I will address several cases that show that such concerns are concrete and not just speculative, from the sharing of UK Biobank data with companies from the insurance industry to the use of genetic data by proponents of racist and eugenic ideas. I will also show the limits of well-established ethical principles in practice and how difficult it is to get unethical research retracted. As the digitalization of genomic and clinical data moves forward and as artificial intelligence allows delving ever deeper into such data, I will discuss some ways to mitigate risks and maintain public trust.
Navigating between assistance and automation: Perspectives on AI’s reshaping of relationships between healthcare providers
By prof. dr. Sigrid Sterckx, Ghent University
The implementation of AI-based systems is already impacting various workflows and hierarchical structures in healthcare, for example through the reallocation of some medical decisions from physicians to AI systems and from physicians to nurses and technicians supported by AI. This not only contributes to a reshaping of the nature of medical decision making itself, but also affects clinical skills at the level of individuals as well as teams, physician-patient relationships, and interprofessional relationships in healthcare. The realisation of added value of AI in healthcare partly depends on profound behaviour changes by clinicians. This, in turn, depends on levels of trust as well as the extent of meaningful (i.e. active) control of the healthcare provider over the AI systems (in contrast to the mere presence of a human in the loop).
Like most technologies, AI systems influence the actions and goals of their users by pushing, pulling, enabling and constraining certain behaviours. In this talk, we will build on a crucial insight from the research domain of Human-Computer Interaction: rather than displacing human activity, digital support and automation transform people’s actions in ways that are often unintended and unexpected by the system designers. From this angle, we will reflect on ways in which AI could transform relationships between healthcare providers by altering the nature of their work, thereby also changing the skills they can(not) develop and the roles and responsibilities they are allocated in their teams. How might healthcare providers come to see themselves and their colleagues, and their role and status in the age of AI?
Enabling trustworthy decision making in healthcare
By prof. dr. ir. Sofie Van Hoecke, IDLab, UGent-imec
When integrating AI/ML-driven models into healthcare, ensuring their trustworthiness is critical for safe and effective decision-making. In this talk we will examine key challenges from real-world use cases. We will explore how explainable AI and uncertainty quantification can enhance model transparency, reliability, and clinical adoption. Through practical examples, we will demonstrate how these methods can strengthen AI-driven decision support in healthcare, ultimately fostering more informed and confident use in healthcare settings.
Data-Driven Healthcare
By prof. dr. Peter De Jaeger, AZ Delta
RADar is actively standardizing and harmonizing healthcare data to ensure the highest quality, especially crucial for its use in AI models. This high data quality standard is vital because the AI models developed are used for personalized and precision medicine, directly impacting patient care. RADar's model development spans a wide range, from classical statistical models to advanced deep learning techniques like masked autoencoders and contrastive learning, ultimately used to predict clinical outcomes. A core focus of RADar is ensuring these models are user-friendly and easily integrated into clinical workflows, directly assisting physicians and other healthcare providers. This emphasis comes from recognizing the necessity of practical usability for effective adoption and utilization in real-world healthcare settings.
AI for Causal Learning: A Smooth Path to Evidence or Evidence on Thin Ice?
By prof. dr. Stijn Vansteelandt, Ghent University
The increasing availability of digital health data, both within and beyond clinical settings, has sparked interest in using "Real World Data" (RWD) to generate "Real World Evidence" (RWE) for medical decision-making. AI and machine learning (ML) are often seen as powerful tools to transform RWD into actionable insights, potentially reducing reliance on costly and time-consuming randomized controlled trials.
In this talk, I will discuss key challenges in using AI for causal inference and explain why standard ML algorithms fail to establish causal relationships. While AI cannot replace rigorous study design and domain expertise, I will show how specially designed causal ML methods can overcome some of these limitations and contribute to meaningful improvements in patient care.
Integrating AI: Data, Devices and Legal considerations
Moderated by Sofie Bekaert, King Baudouin Foundation & Ghent University
Discussion time! Building on the discussion, this session will examine how existing legal frameworks apply to AI-related healthcare incidents and what gaps remain. It will highlight potential policy recommendations and legal precedents shaping the future of AI liability.
AI Act in Medicine
By dr. Sofia Palmieri, VUB
The AI Act is set to reshape the medical landscape by introducing regulatory requirements for AI-driven solutions. This session will explore its implications on medical innovation, patient safety, and compliance, focusing on risk classification, transparency, and ethical considerations.
Medical Device Regulation (MDR) & AI Act
By Lieselot Burggraeve, Ghent University & Azalea Vision
Medical Device Regulation (MDR) intersects with the AI Act, creating a complex compliance environment. This response session will assess how medical AI applications navigate the dual regulatory framework, addressing challenges for developers and healthcare providers.
European Health Data Space (EHDS)
By Griet Verhenneman, Ghent University
The European Health Data Space (EHDS) aims to facilitate secure health data sharing across the EU while ensuring patient privacy. This session will discuss its potential for research, innovation, and cross-border healthcare, as well as key legal and ethical challenges.
Data Quality
By Jens Declerck, i~HD, European Institute for Innovation Through Health Data
High-quality data is the foundation of reliable AI in healthcare. This response session will address the challenges of data accuracy, bias mitigation, and standardization, particularly in light of EHDS implementation.
AI Liability
By Sofia Palmieri, i~HD, European Institute for Innovation Through Health Data
As AI takes on a greater role in clinical decision-making, questions of legal responsibility become critical. This session will explore liability frameworks, from malpractice considerations to accountability for AI-driven errors in patient care.
Liability
By Sylvie Tack, Sanalex, Ghent University, UAntwerpen
Building on the discussion, this session will examine how existing legal frameworks apply to AI-related healthcare incidents and what gaps remain. It will highlight potential policy recommendations and legal precedents shaping the future of AI liability.
Teachers/speakers
Tom Braekeleirs
Tom Braekeleirs is een healthnerd en innovatieleider op het gebied van digitale gezondheid. Hij heeft meer dan 25 jaar ervaring in de IT-industrie en werkte voor bedrijven als EDS-AT Kearney, Navision en Microsoft. In 2015 maakte hij een carrièreswitch om leiding te geven aan het BlueHealth Innovation Center, een vzw actief in digitalisering in de gezondheidszorg. Midden 2023 werd deze organisatie onderdeel van imec, waarna Tom spreker werd bij Nexxworks en Nexxtt.Health oprichtte. Hij is ook professor Digitale Medische Technologie aan de UGent (faculteit Gezondheidswetenschappen). Hij is adviseur, podcaster, spreker, docent en columnist over onderwerpen als de toekomst van gezondheid, digitale technologie en ondernemerschap. In 2022 ontving hij de PRoF Award for Innovation voor zijn bijdrage aan het bevorderen van digitale innovatie in de gezondheidszorg. Zijn persoonlijke motto is: "Change the world or go home!"
Kirsten Colpaert
I am an Associate Professor at Ghent University and an intensivist at
Ghent University Hospital, specializing in neuro-intensive care and
burns. My career bridges clinical expertise, academic research, and
innovation in healthcare data science.
In 2013, I completed my
PhD on quality improvement through information technology, focusing on
how digital tools can enhance patient care. This work laid the
foundation for my passion for combining clinical practice with
data-driven innovation.
I am the founder and medical director of
the Data Science Institute (DSI) at UZ Gent, where I lead initiatives to
integrate business intelligence and advanced data science into
healthcare operations. My dual role as an ICU physician and DSI director
allows me to connect frontline clinical care with cutting-edge data
solutions.
Maarten De Vos
Prof. dr. Maarten De Vos is hoogleraar aan de faculteiten Ingenieurswetenschappen en Geneeskunde van KU Leuven. Hij richt zich op het verbeteren van data science-benaderingen voor verschillende toepassingen in de gezondheidszorg. Zijn AI-oplossingen worden gebruikt op verschillende ziekenhuisafdelingen, variërend van neonatologie tot ouderenzorg.
Seppe Segers
Seppe Segers is a professor of ethics and moral science at the department of Philosophy and Moral Sciences, Ghent University.
His main research and teaching interests concern the domains of theoretical and substantive ethics, moral science and value theory.
Yves Moreau
Yves Moreau is a professor at KU Leuven ESAT STADIUS.
His team focuses on AI algorithms and software platforms for the integration of complex data in clinical genomics and drug discovery:
- federated analysis of real-world clinical and genomic data,
- data fusion algorithms for the identification of pathogenic genetic variation in rare genetic disorders and liquid biopsies, and
- data fusion for drug discovery and drug design.
At the algorithmic level, Prof. Moreau focuses on the development of novel AI methods, such as deep learning and Bayesian matrix factorization, for the fusion of heterogeneous sparsely-observed data; and on privacy-preserving implementations of such methods. He aims at demonstrated clinical or industrial applicability of his methods and proven effectiveness in human genetics research and drug discovery.
Prof. Moreau is engaged in a reflection on how information technology
and artificial intelligence are transforming our world and on how to
make sure this transformation is beneficial for all. In particular, I am
actively pushing back against the emergence of surveillance societies that has been made possible by such technological advances.
Prof. Moreau is am also a tech innovator
interested in identifying relevant business models for emerging
technologies and developing projects up to the precompetitive stage and
the startup of university spin-offs. He is a co-founder of Data4S, a
data mining company specialized in fraud detection and
anti-moneylaundering, which is now part of BAE Systems, Detica
NetReveal. He is also a co-founder of Cartagenia (taken over by Agilent
Technologies), specialized in ICT solutions for clinical genetic
diagnosis.
Sigrid Sterckx
Sigrid Sterckx, PhD, is Professor of Ethics and Political and Social Philosophy at the Department of Philosophy and Moral Sciences of Ghent University. She is a founding member of the Bioethics Institute Ghent. She lectures courses in theoretical and applied ethics as well as social and political philosophy and global ethics. Her current research projects focus on: global justice (with particular attention to climate change and economic governance); human tissue research and biobanking; patenting in biomedicine and genomics; organ transplantation; neurosciences, criminal law and ethics; and end-of-life decisions.
She is a permanent research associate of the Centre for Health, Law, and Emerging Technologies, Department of Population Health, University of Oxford (UK), as well as an associate member of the Centre for the Study of Global Ethics, Department of Philosophy, the University of Birmingham (UK).
Sigrid also serves on various advisory committees, including the Belgian Advisory Committee on Bioethics, which advises the Federal Government of Belgium, and the Ethics Committee of Ghent University Hospital.
Sofie Van Hoecke
Sofie Van Hoecke graduated from the Engineering Department from the Ghent University in 2003. Following up on her studies in computer science, she achieved a PhD in computer science engineering at the Department of Information Technology at the same university on Efficient service management in healthcare. After being a postdoctoral research engineer at the Department of Information Technology, she started as lecturer ICT and ICT research coordinator at the University College West-Flanders. Currently, she is associate professor at Ghent University, IDLab - Data Science Lab.
Her specialties are: multi-sensor and service oriented architectures, novel services, condition monitoring, emotion recognition, machine learning, semantic dashboards, and the fusion of machine learning and semantic technologies, applied in both predictive maintenance and predictive healthcare.
Peter De Jaeger
Prof. Peter De Jaeger is director IT & data and the Chief Innovation Officer and leading RADar, the learning and innovation centre of AZ Delta. He holds a position at Hasselt University as a data science professor and a position as adjunct associate professor at University College Dublin. His working experience deals with project management, research & development, product development, clinical studies, data access/use/sharing.
Stijn Vansteelandt
I am a biostatistician with over 20 years of experience in the development of statistical methods for causal inference. I have spent most of my career at Ghent University, except for postdoctoral training under the guidance of Andrea Rotnitzky and James Robins at the Department of Biostatistics of the Harvard School of Public Health, and a part-time professorship as Professor of Statistical Methodology at the Department of Medical Statistics at the London School of Hygiene and Tropical Medicine from 2017 to 2021.
I have had the privilege of serving as Co-Editor of Biometrics, the flagship journal of the International Biometric Society. Furthermore, I have contributed as an Associate Editor for several prestigious journals including the American Journal of Epidemiology, Biometrics, Biostatistics, Epidemiology, Epidemiologic Methods, the Journal of Causal Inference, and the Journal of the Royal Statistical SocietySeries B. I have been awarded an advanced ERC grant by the European Research Council in 2024.
Expertise: Causal machine learning, causal inference, statistical data analysis, semi-parametric statistics
Anastasyia Kiseleva
Anastasiya Kiseleva is doing international and interdisciplinary PhD research funded and supported by the EUTOPIA program.
Her research is about balancing AI's transparency in healthcare with its safety and quality from legal and technical perspectives. The project is organised in collaboration between Vrije Universiteit Brussels as a home university (represented by the Research Group Law, Science, Technology and Society (LSTS) responsible for legal expertise) and CY Cergy University Paris as a host university (represented by ETIS Research Lab and leading the technical area of the project).
Anastasiya works on different topics in health law and technologies, including the European Health Data Space, AI-based medical devices, genetic testing and editing with AI. Her papers in the mentioned areas were top listed by the publishing journals and cited by the European Parliament and the European Commission. She is a member of Ethics Advisory Boards in several EU-funded projects such as DigiCare4You and Marvel. Since June 2023, she joined the Editorial Board of the European Health & Pharmaceutical Law Review. She acts as an external AI Policy Expert at EUMASS (the European Union of Medicine in Assurance and Social Security).
Anastasiya holds an LL.M. in IP & IT Law (EULISP) from Leibniz University Hannover (magna cum laude). Before fully focusing her career on academia, she has been previously practicing intellectual property and information technology law for more than 8 years.
Lieselot Burggraeve
- Project management of non-commercial medical device investigations
- Ethical committee and competent authority submission for medical device investigations
- Advise on regulatory, quality and clinical aspects during the design and development of medical devices in an academic setting
- Training on regulatory and clinical affairs for medical devices
- Setting up a quality management system for the conduct of clinical studies
Griet Verhenneman
Prof. Dr. Griet Verhenneman is Assistant Professor of Privacy Law at Ghent University. For more than 15 years, Griet has been working on IT law, developing a particular interest in the legal aspects of eHealth, privacy and data protection. At KU Leuven - CiTiP Prof. Verhenneman currently holds the position of lecturer on European Privacy and Data Protection Law in the Advanced Master IP – IT Law and is involved as an affiliated researcher in the health research group.
Jens Declerck
Expertise:
- Data quality and biases towards AI
- Explainability using data quality assessments
- Understanding data sources towards extracting and harmonizing data for training AI
- How AI might bring value in hospitals and specific towards creating more data quality maturity
Sofia Palmieri
Sofia Palmieri is a FWO Junior Postdoctoral Fellow at Ghent University and Healthcare AI Policy and Compliance Officer at the European Institute for Innovation through Health Data (i~HD). Her research is positioned at a crossroads between legal, ethics, AI and healthcare. She investigates the perimeter of regulation for the safe, patient-centred and evidence-based use of Artificial Intelligence in the medical field. After receiving a Master's Degree in Law (magna cum laude) from the University of Bologna, she specialized in Ethics and Life Science at the same Alma Mater. She spent a period of research both at Paris Nanterre University and at KU Leuven. She also joined AI4Health as a member of the core team. Recently, she started as co-chair of the Young Scholar Interest Group of the European Association of Health Law.
Sylvie Tack
Doctor in de Rechten bij Sanalex Advocaten en gastprofessor bij UGent en UAntwerpen
Related courses